Has Salih Selek, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,311 in general payments to Salih Selek, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Salih Selek, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Salih Selek, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Salih Selek, MD

Psychiatry · Houston, TXNPI 1376933804

Payments from drug & device makers

$1,311in general payments, 2019–2025

Across 53 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$334
AbbVie$243
Otsuka America Pharmaceutical, Inc.$118
Livanova USA, Inc.$113
Lundbeck LLC$99
Johnson & Johnson$90
plus $313 from 8 others

What the payments were for

Food & beverage$1,311100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	7	$334
AbbVie	13	$243
Otsuka America Pharmaceutical, Inc.	6	$118
Livanova USA, Inc.	1	$113
Lundbeck LLC	5	$99
Johnson & Johnson	4	$90
Takeda Pharmaceuticals U.S.A., Inc.	3	$60
Vanda Pharmaceuticals Inc.	3	$53
Corium, LLC	3	$47
Neurocrine Biosciences, Inc.	3	$47
Brainsway USA Inc	2	$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$21
Ironshore Pharmaceuticals Inc.	1	$20
Axsome Therapeutics, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$170
VNS Therapy Symmetry Model 8103 Generator$113

How this compares

$1,311 in reported general payments places this provider in the 70th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024

$17,689

Medicare patients

Services billed

173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lurasidone Hcl	23	$10,877
Paliperidone ErPaliperidone	44	$7,925
Aripiprazole	30	$4,222
Divalproex Sodium ErDivalproex Sodium	24	$1,265
Bupropion XlBupropion Hcl	37	$740
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	26	$639
Buspirone Hcl	72	$535
Benztropine Mesylate	40	$448
Gabapentin	54	$359
Trazodone Hcl	59	$295
Olanzapine	28	$240
Clonazepam	39	$239
Hydroxyzine Hcl	28	$231
Venlafaxine Hcl ErVenlafaxine Hcl	26	$211
Duloxetine Hcl	31	$199

Paid to pharmacies, not to this prescriber.

Other psychiatry in Houston

Matthew BramsHouston$3M
Lawrence GinsbergHouston$2.4M
Asim ShahHouston$2.2M
Aqeel HashmiHouston$1.3M
Robert EarleHouston$1.1M
Frank ChenHouston$941K
Joao de QuevedoHouston$890K
Alice MaoHouston$850K
Mazhar KhowajaHouston$843K
Barry GritzHouston$792K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →